HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bernard Weill Selected Research

Systemic Scleroderma (Systemic Sclerosis)

10/2015Inhibition of EGFR Tyrosine Kinase by Erlotinib Prevents Sclerodermatous Graft-Versus-Host Disease in a Mouse Model.
7/2015Pantethine Prevents Murine Systemic Sclerosis Through the Inhibition of Microparticle Shedding.
10/2013The natural organosulfur compound dipropyltetrasulfide prevents HOCl-induced systemic sclerosis in the mouse.
10/2012Reactive oxygen species-mediated killing of activated fibroblasts by arsenic trioxide ameliorates fibrosis in a murine model of systemic sclerosis.
7/2010Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis.
5/2009Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse.
4/2007Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bernard Weill Research Topics

Disease

14Neoplasms (Cancer)
01/2019 - 02/2005
10Fibrosis (Cirrhosis)
10/2016 - 05/2009
7Systemic Scleroderma (Systemic Sclerosis)
10/2015 - 04/2007
7Endometriosis
01/2013 - 07/2009
4Colonic Neoplasms (Colon Cancer)
01/2017 - 02/2006
4Inflammation (Inflammations)
10/2015 - 07/2009
3Peripheral Nervous System Diseases (PNS Diseases)
01/2019 - 01/2014
3Vasculitis (Vasculitides)
12/2011 - 07/2007
3Autoimmune Diseases (Autoimmune Disease)
05/2009 - 01/2003
2Demyelinating Diseases (Demyelinating Disease)
01/2019 - 01/2017
2Necrosis
02/2016 - 11/2003
2Graft vs Host Disease (Graft-Versus-Host Disease)
10/2015 - 05/2012
2Bronchiolitis Obliterans Syndrome
10/2015 - 05/2012
2Hepatocellular Carcinoma (Hepatoma)
10/2012 - 12/2002
2Reperfusion Injury
10/2011 - 01/2011
2Lung Neoplasms (Lung Cancer)
09/2011 - 07/2006
2Infections
12/2005 - 01/2005
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2005 - 12/2003
2Acute Liver Failure (Fulminant Hepatic Failure)
11/2003 - 05/2002
1Parkinson Disease (Parkinson's Disease)
01/2019
1Multiple Sclerosis
01/2019
1Neuralgia (Stump Neuralgia)
01/2017
1Hypesthesia (Numbness)
01/2017
1Hyperalgesia
01/2017
1Colorectal Neoplasms (Colorectal Cancer)
01/2017
1Neuroinflammatory Diseases
01/2017
1Carcinoma (Carcinomatosis)
01/2014
1Human Influenza (Influenza)
08/2013
1Dyspareunia
01/2013
1Pelvic Pain
01/2013
1Dysmenorrhea (Menstrual Pain)
07/2012
1Acute Promyelocytic Leukemia
05/2012
1HIV Infections (HIV Infection)
02/2012

Drug/Important Bio-Agent (IBA)

10Reactive Oxygen Species (Oxygen Radicals)IBA
01/2014 - 11/2003
5N,N'- bis(pyridoxal- 5- phosphate)ethylenediamine- N,N'- diacetic acid (mangafodipir)FDA Link
01/2014 - 02/2005
5AutoantibodiesIBA
06/2012 - 01/2005
5Proteins (Proteins, Gene)FDA Link
02/2012 - 05/2002
4Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019 - 02/2005
4Superoxides (Superoxide)IBA
02/2016 - 05/2004
4AntibodiesIBA
07/2011 - 04/2007
3Aligeron (AS 2)IBA
12/2012 - 05/2012
3Arsenic Trioxide (Trisenox)FDA Link
12/2012 - 05/2012
3Type I DNA Topoisomerases (Topoisomerase I)IBA
06/2012 - 05/2009
3AntioxidantsIBA
07/2009 - 05/2004
2PlatinumIBA
01/2019 - 01/2017
2Bleomycin (Blenoxane)FDA LinkGeneric
10/2016 - 05/2009
2AnionsIBA
02/2016 - 05/2009
2CollagenIBA
05/2013 - 10/2012
2manganese(III)-tetrakis(4-benzoic acid)porphyrinIBA
10/2012 - 05/2004
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
02/2012 - 12/2002
2Methotrexate (Mexate)FDA LinkGeneric
10/2010 - 01/2005
2Hypochlorous Acid (Hypochlorite)IBA
07/2010 - 05/2009
2DNA (Deoxyribonucleic Acid)IBA
07/2010 - 05/2002
2CatalaseIBA
07/2009 - 02/2005
2Mitogen-Activated Protein KinasesIBA
07/2009 - 02/2005
2Paclitaxel (Taxol)FDA LinkGeneric
07/2006 - 02/2006
2Interleukin-6 (Interleukin 6)IBA
12/2005 - 01/2005
2Messenger RNA (mRNA)IBA
12/2005 - 12/2002
2Immunoglobulin G (IgG)IBA
11/2005 - 01/2003
2Acetaminophen (Paracetamol)FDA LinkGeneric
09/2005 - 11/2003
2Intravenous Immunoglobulins (IVIG)FDA Link
12/2003 - 01/2003
1Histamine (Histamine Dihydrochloride)FDA Link
01/2019
1Muscarinic M3 ReceptorIBA
01/2019
1Cholinergic Agents (Cholinergics)IBA
01/2019
1Platinum Compounds (Compounds, Platinum)IBA
01/2019
1CytokinesIBA
01/2019
1Benztropine (Benzatropine)FDA LinkGeneric
01/2019
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2019
1Dopamine (Intropin)FDA LinkGeneric
01/2019
1NiclosamideFDA Link
01/2017
1pantetheinase (pantetheine hydrolase)IBA
10/2016
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2015
1Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2015
1Minor Histocompatibility AntigensIBA
10/2015
1pantethineIBA
07/2015
1Chalcone (Benzalacetophenone)IBA
01/2014
1CoumarinsIBA
01/2014
1dipropyl tetrasulfideIBA
10/2013
1Anti-Bacterial Agents (Antibiotics)IBA
10/2013
1Rheumatoid FactorIBA
08/2013
1Angiotensin Receptors (Angiotensin II Receptor)IBA
05/2013
1Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2013
1IrbesartanFDA LinkGeneric
05/2013
1Interleukin-22 (IL-22)IBA
01/2013
1InterleukinsIBA
01/2013
1Interleukin-10 (Interleukin 10)IBA
01/2013
1Sorafenib (BAY 43-9006)FDA Link
10/2012
1Interleukin-33IBA
07/2012
1Sunitinib (Sutent)FDA Link
06/2012
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2012
1OilsIBA
12/2011
1MineralsIBA
12/2011
1pristane (pristan)IBA
12/2011
1PhytolIBA
12/2011
1Retinaldehyde (Retinal)IBA
12/2011

Therapy/Procedure

3Injections
06/2012 - 02/2007
2Drug Therapy (Chemotherapy)
01/2019 - 01/2017
2Hematopoietic Stem Cell Transplantation
10/2015 - 05/2012
2Therapeutics
10/2012 - 01/2005